Form 4 holding
EVP, Research and Development and Chief Medical Officer
ANTARES PHARMA, INC.
- Security class
- Common Stock
- Shares / value
- 0
- Estimated value
- Report date
- 24 May 2022
- Price
- $5.60
- Ownership
- Direct
Peter C. Richardson - EVP, Research and Development and Chief Medical Officer at ANTARES PHARMA, INC.
Insider Transactions and Holdings
- Entity type
- Individual
- Role
- EVP, Research and Development and Chief Medical Officer
- Issuer symbol
- ATRS
- Source filings
- Open source filing history
Identity
Issuer context
SEC evidence
There are no Buy or Sell transactions made by Peter C. Richardson since 01 Jun 2025
Holdings reported by Peter C. Richardson for ANTARES PHARMA, INC.
Form 4 holding
EVP, Research and Development and Chief Medical Officer
ANTARES PHARMA, INC.
- Security class
- Stock Option (right to buy)
- Shares / value
- 0
- Estimated value
- Report date
- 24 May 2022
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transactions reported by Peter C. Richardson for ANTARES PHARMA, INC.
| Sym | Class | Transaction | % | Reported value | Reported price | Shares | Shares after | Date | Ownership |
|---|
* indicates a reported price that failed the local validity check.